Novel conjugate of moxifloxacin and carboxymethylated glucan with enhanced activity against Mycobacterium tuberculosis.
Schwartz YS, Dushkin MI, Vavilin VA, Melnikova EV, Khoschenko OM, Kozlov VA, Agafonov AP, Alekseev AY, Rassadkin Y, Shestapalov AM, Azaev MS, Saraev DV, Filimonov PN, Kurunov Y, Svistelnik AV, Krasnov VA, Pathak A, Derrick SC, Reynolds RC, Morris S, Blinov VM.
Schwartz YS, et al. Among authors: svistelnik av.
Antimicrob Agents Chemother. 2006 Jun;50(6):1982-8. doi: 10.1128/AAC.00362-05.
Antimicrob Agents Chemother. 2006.
PMID: 16723555
Free PMC article.